0000899243-20-019207.txt : 20200715 0000899243-20-019207.hdr.sgml : 20200715 20200715181649 ACCESSION NUMBER: 0000899243-20-019207 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200713 FILED AS OF DATE: 20200715 DATE AS OF CHANGE: 20200715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Invest Corp CENTRAL INDEX KEY: 0001534428 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201030338 BUSINESS ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 0119611363362 MAIL ADDRESS: STREET 1: C/O PILLAR INVEST OFFSHORE SAL STREET 2: STARCO CENTER, BLOC B FL3, OMAR DAOUK ST CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pillar Partners Foundation, L.P. CENTRAL INDEX KEY: 0001783583 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201030339 BUSINESS ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 BUSINESS PHONE: 961 1 363 362 MAIL ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Umari Abude CENTRAL INDEX KEY: 0001783582 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201030340 MAIL ADDRESS: STREET 1: STARCO CTR, BLOC B, 3RD FLOOR STREET 2: OMAR DAUOK STREET CITY: BEIRUT STATE: M8 ZIP: 2020-3313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZEIN YOUSSEF EL CENTRAL INDEX KEY: 0001193366 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 201030341 MAIL ADDRESS: STREET 1: HYBRIDON INC STREET 2: 345 VASSAR STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 4843481600 MAIL ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-13 0 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001534428 Pillar Invest Corp PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001783583 Pillar Partners Foundation, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001783582 Umari Abude PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 0001193366 ZEIN YOUSSEF EL PILLAR INVEST OFFSHORE SAL, STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT M8 2020-3313 LEBANON 0 0 1 0 Common Stock 2020-07-13 4 P 0 749993 1.72 A 5427697 I By Pillar Partners Foundation, L.P. See Footnotes Common Stock 21100 I By Pillar Pharmaceuticals I, L.P. See Footnote Common Stock 20820 I By Pillar Pharmaceuticals II, L.P. See Footnote Common Stock 29998 I By Pillar Pharmaceuticals III, L.P. See Footnote Common Stock 1000 I By Pillar Pharmaceuticals IV, L.P. See Footnote Common Stock 25000 I By Pillar Pharmaceuticals V, L.P. See Footnote Common Stock 1288368 I By Pillar Pharmaceuticals 6, L.P. See Footnote Common Stock 6724 I By Youssef El Zein See Footnote Common Stock 190117 I By Abude Umari See Footnotes Prefunded Warrants 2020-07-13 4 P 0 2014234 0.00 A Common Stock 2014234 2014234 I By Pillar Partners Foundation, L.P. See Footnote Common Warrants 2020-07-13 4 P 0 2764227 0.00 A Common Stock 2764227 2764227 I By Pillar Partners Foundation, L.P. See Footnote On July 13, 2020, upon the consummation of a private placement of the Issuer (the "Private Placement"), Pillar Partners Foundation, L.P. ("Pillar Foundation"), acquired, in the Private Placement, (i) 749,993 shares of common stock (the "Pillar Foundation Shares") (ii) pre-funded warrants to purchase 2,014,234 shares of common stock of the Issuer (the "Prefunded Warrants") and (iii) warrants to purchase 2,764,267 shares of common stock of the Issuer (the "Common Warrants" and together with the Prefunded Warrants, the "Pillar Foundation Warrants"). The price per share for the Pillar Foundation Shares was $1.72, and the price per Pillar Foundation Warrant was $0.125. Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals I, L.P., Pillar Pharmaceuticals II, L.P., Pillar Pharmaceuticals III, L.P., Pillar Pharmaceuticals IV, L.P., Pillar Pharmaceuticals V, L.P., Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Foundation (collectively, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable. Includes 103,891 shares received in a prior pro rata, without value distribution from Pillar 6, and 46,304 shares received in a prior pro rata, without value distribution from Pillar Foundation. These distributions were effected in compliance with the exemptions afforded pursuant to Rule 16a-9 and Rule 16a-13 of the Securities Exchange Act of 1934, as amended. The exercise price of each Prefunded Warrant is $0.01 per Share, subject to adjustment pursuant to the terms of the Prefunded Warrants. The Pre-funded warrants have no expiration date and are exercisable immediately, to the extent that after giving effect to such exercise the holders thereof and their affiliates would beneficially own, for purposes of Rule 13d-3 under the Securities Act of 1934, as amended, no more than 19.99% of the outstanding shares of Common Stock (the "Beneficial Ownership Limitation"). The exercise price of each Common Warrant is $2.58 per share, subject to adjustment pursuant to the terms of the Common Warrants. The Common Warrants are currently exercisable; provided, however, that the Common Warrants are subject to the Beneficial Ownership Limitation. The Common Warrants expire 3 years following their issuance date. Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person 2020-07-15 Pillar Partners Foundation, L.P., /s/ Youssef El Zein, Authorized Person 2020-07-15 /s/ Abude Umari 2020-07-15 /s/ Youssef El Zein 2020-07-15